Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TropicALL study
NL-OMON23171Suspended
- Sponsor
- Dutch Childhood Oncology Group (DCOG) Stichting Kinderoncologie Nederland (SKION)
- Start
- Oct 2014
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, open-label trial of nadroparin in acute lymphoblastic leukemia (ALL) (2 arms), sponsored by Dutch Childhood Oncology Group (DCOG) Stichting Kinderoncologie Nederland (SKION). Primary endpoint: Incidence of symptomatic objectified venous thromboembolism. Started Oct 2014; status: suspended.
02
Drugs
nadroparin
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NL-OMON23171.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON23171.